Skip to main content
Top
Published in: Clinical Rheumatology 8/2017

01-08-2017 | Original Article

Metabolic characteristics and renal dysfunction in 65 patients with tophi prior to gout

Authors: Chuan-Chin Lu, Shyi-Kuen Wu, Wei-Sheng Chung, Liang-Hung Lin, Ta-Wei Hung, Chih-Jung Yeh

Published in: Clinical Rheumatology | Issue 8/2017

Login to get access

Abstract

Tophi typically occur many years after uncontrolled gout. Therefore, their development before gout remains unusual. Such patients might exhibit some characteristic differences compared with typical tophaceous gout patients. In this study, 65 tophaceous gout patients with tophi as the first sign of gout (tophi-first group) were enrolled. Their clinical characteristics were compared with those of 1421 patients whose tophi occurred after gout (tophi-after group). Compared with the tophi-after group, the tophi-first group had a significantly higher percentage of female patients and patients with elderly onset of disease and a lower percentage of patients with a positive family history; these patients had lower body mass indices, serum urate levels, and estimated glomerular filtration rates (eGFRs). Female sex and negative family history were identified as the principal determinants of tophi development before gout. The decreasing eGFR among the tophi-first group was not due to the group per se but was a result of older age, longer tophi duration, and hyperuricemia. The most common site of initial tophi occurrence in both groups was the toe. In the tophi-first group, the occurrence rates for initial tophi sites were significantly higher at the finger but were lower at the ankle. The tophi-first group exhibited distinct characteristics of age, gender, family history, BMI, serum urate levels, and initial tophi site. This group had fewer comorbidities but similar renal dysfunction compared with the tophi-after group. Thus, patients presenting with tophi should be treated promptly, even if they have no history of gout symptoms.
Literature
1.
go back to reference Wernick R, Winkler C, Campbell S (1992) Tophi as the initial manifestation of gout: report of six cases and review of the literature. Arch Intern Med 152(4):873–876CrossRefPubMed Wernick R, Winkler C, Campbell S (1992) Tophi as the initial manifestation of gout: report of six cases and review of the literature. Arch Intern Med 152(4):873–876CrossRefPubMed
2.
go back to reference López Redondo MJ, Requena L, Macía M, Schoendorff C, Sánchez Yus E, Robledo A (1993) Fingertip tophi without gouty arthritis. Dermatology 187(2):140–143CrossRefPubMed López Redondo MJ, Requena L, Macía M, Schoendorff C, Sánchez Yus E, Robledo A (1993) Fingertip tophi without gouty arthritis. Dermatology 187(2):140–143CrossRefPubMed
3.
go back to reference Iglesias A, Londono JC, Saaibi DL, Peña M, Lizarazo H, Gonzalez EB (1996) Gout nodulosis: widespread subcutaneous deposits without gout. Arthritis Care Res 9(1):74–77CrossRefPubMed Iglesias A, Londono JC, Saaibi DL, Peña M, Lizarazo H, Gonzalez EB (1996) Gout nodulosis: widespread subcutaneous deposits without gout. Arthritis Care Res 9(1):74–77CrossRefPubMed
6.
go back to reference Koley S, Salodkar A, Choudhary S, Bhake A, Singhania K, Choudhury M (2010) Tophi as first manifestation of gout. Indian J Dermatol Venereol Leprol 76(4):393–396CrossRefPubMed Koley S, Salodkar A, Choudhary S, Bhake A, Singhania K, Choudhury M (2010) Tophi as first manifestation of gout. Indian J Dermatol Venereol Leprol 76(4):393–396CrossRefPubMed
7.
go back to reference Ayvazoglu Soy EH, Karakaya E, Karatas Togral A, Akdur A, Moray G, Haberal M (2015) Dermal tophus: a complication of gout in a kidney transplant recipient. Exp Clin Transplant Suppl 1:276–279CrossRef Ayvazoglu Soy EH, Karakaya E, Karatas Togral A, Akdur A, Moray G, Haberal M (2015) Dermal tophus: a complication of gout in a kidney transplant recipient. Exp Clin Transplant Suppl 1:276–279CrossRef
8.
go back to reference Kumar R, Sahni VK, Jauhar S (2015) Finger flexion contracture: first manifestation of gout. J Orthop Case Rep 5(2):66–68PubMedPubMedCentral Kumar R, Sahni VK, Jauhar S (2015) Finger flexion contracture: first manifestation of gout. J Orthop Case Rep 5(2):66–68PubMedPubMedCentral
9.
11.
go back to reference Sharifabad MA, Tzeng J, Gharibshahi S (2006) Mammary gouty tophus: a case report and review of the literature. Breast J 12(3):263–265CrossRefPubMed Sharifabad MA, Tzeng J, Gharibshahi S (2006) Mammary gouty tophus: a case report and review of the literature. Breast J 12(3):263–265CrossRefPubMed
15.
17.
go back to reference Nakayama DA, Barthelemy C, Carrera G, Lightfoot RW Jr, Wortmann RL (1984) Tophaceous gout: a clinical and radiographic assessment. Arthritis Rheum 27(4):468–471CrossRefPubMed Nakayama DA, Barthelemy C, Carrera G, Lightfoot RW Jr, Wortmann RL (1984) Tophaceous gout: a clinical and radiographic assessment. Arthritis Rheum 27(4):468–471CrossRefPubMed
18.
go back to reference Lu CC, Wu SK, Chen HY, Chung WS, Lee MC, Yeh CJ (2014) Clinical characteristics of and relationship between metabolic components and renal function among patients with early-onset juvenile tophaceous gout. J Rheumatol 41(9):1878–1883. doi:10.3899/jrheum.131240 CrossRefPubMed Lu CC, Wu SK, Chen HY, Chung WS, Lee MC, Yeh CJ (2014) Clinical characteristics of and relationship between metabolic components and renal function among patients with early-onset juvenile tophaceous gout. J Rheumatol 41(9):1878–1883. doi:10.​3899/​jrheum.​131240 CrossRefPubMed
19.
go back to reference Perez-Ruiz F, Martínez-Indart L, Carmona L, Herrero-Beites AM, Pijoan JI, Krishnan E (2014) Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout. Ann Rheum Dis 73:177–182. doi:10.1136/annrheumdis-2012-202421 CrossRefPubMed Perez-Ruiz F, Martínez-Indart L, Carmona L, Herrero-Beites AM, Pijoan JI, Krishnan E (2014) Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout. Ann Rheum Dis 73:177–182. doi:10.​1136/​annrheumdis-2012-202421 CrossRefPubMed
20.
go back to reference Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yü TF (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20(3):895–900CrossRefPubMed Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yü TF (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20(3):895–900CrossRefPubMed
21.
go back to reference Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJ, Lioté F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vaquez-Mellado J, Yarows SA, Taylor WJ (2015) 2015 gout classification criteria: an American College of Rheumatology/European league against Rheumatism collaborative initiative. Ann Rheum Dis 74(10):1789–1798CrossRefPubMedPubMedCentral Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJ, Lioté F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vaquez-Mellado J, Yarows SA, Taylor WJ (2015) 2015 gout classification criteria: an American College of Rheumatology/European league against Rheumatism collaborative initiative. Ann Rheum Dis 74(10):1789–1798CrossRefPubMedPubMedCentral
22.
go back to reference Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145(4):247–254CrossRefPubMed Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145(4):247–254CrossRefPubMed
25.
go back to reference De Souza A, Fernandes V, Ferrari AJ (2005) Female gout: clinical and laboratory features. J Rheumatol 32(11):2186–2188PubMed De Souza A, Fernandes V, Ferrari AJ (2005) Female gout: clinical and laboratory features. J Rheumatol 32(11):2186–2188PubMed
26.
go back to reference Chang SJ, Chen CJ, Tsai FC, Lai HM, Tsai PC, Tsai MH, Ko YC (2008) Association between gout tophus and polymorphisms 869T/C and -509C/T in transforming growth factor beta1 gene. Rheumatology 47(5):617–621CrossRefPubMed Chang SJ, Chen CJ, Tsai FC, Lai HM, Tsai PC, Tsai MH, Ko YC (2008) Association between gout tophus and polymorphisms 869T/C and -509C/T in transforming growth factor beta1 gene. Rheumatology 47(5):617–621CrossRefPubMed
27.
30.
go back to reference Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, Ravussin E, Stephens JM, Dixit VD (2011) The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 17(2):179–188. doi:10.1038/nm.2279 CrossRefPubMedPubMedCentral Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, Ravussin E, Stephens JM, Dixit VD (2011) The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 17(2):179–188. doi:10.​1038/​nm.​2279 CrossRefPubMedPubMedCentral
31.
go back to reference Wree A, McGeough MD, Peña CA, Schlattjan M, Li H, Inzaugarat ME, Messer K, Canbay A, Hoffman HM, Feldstein AE (2014) NLRP3 inflammasome activation is required for fibrosis development in NAFLD. J Mol Med (Berl) 92(10):1069–1082. doi:10.1007/s00109-014-1170-1 CrossRef Wree A, McGeough MD, Peña CA, Schlattjan M, Li H, Inzaugarat ME, Messer K, Canbay A, Hoffman HM, Feldstein AE (2014) NLRP3 inflammasome activation is required for fibrosis development in NAFLD. J Mol Med (Berl) 92(10):1069–1082. doi:10.​1007/​s00109-014-1170-1 CrossRef
32.
go back to reference Dalbeth N, Pool B, Gamble GD, Smith T, Callon KE, McQueen FM, Cornish J (2010) Cellular characterization of the gouty tophus: a quantitative analysis. Arthritis Rheum 62(5):1549–1556. doi:10.1002/art.27356 CrossRefPubMed Dalbeth N, Pool B, Gamble GD, Smith T, Callon KE, McQueen FM, Cornish J (2010) Cellular characterization of the gouty tophus: a quantitative analysis. Arthritis Rheum 62(5):1549–1556. doi:10.​1002/​art.​27356 CrossRefPubMed
33.
34.
go back to reference Goldberg EL, Asher JL, Molony RD, Shaw AC, Zeiss CJ, Wang C, Morozova-Roche LA, Herzog RI, Iwasaki A, Dixit VD (2017) β-Hydroxybutyrate deactivates neutrophil NLRP3 Inflammasome to relieve gout flares. Cell Rep 18(9):2077–2087. doi:10.1016/j.celrep.02.004 CrossRefPubMed Goldberg EL, Asher JL, Molony RD, Shaw AC, Zeiss CJ, Wang C, Morozova-Roche LA, Herzog RI, Iwasaki A, Dixit VD (2017) β-Hydroxybutyrate deactivates neutrophil NLRP3 Inflammasome to relieve gout flares. Cell Rep 18(9):2077–2087. doi:10.​1016/​j.​celrep.​02.​004 CrossRefPubMed
35.
go back to reference Vieira AT, Macia L, Galvão I, Martins FS, Canesso MC, Amaral FA, Garcia CC, Maslowski KM, De Leon E, Shim D, Nicoli JR, Harper JL, Teixeira MM, Mackay CR (2015) A role for gut microbiota and the metabolite-sensing receptor GPR43 in a murine Model of gout. Arthritis Rheumatol 67(6):1646–1656. doi:10.1002/art.39107 CrossRefPubMed Vieira AT, Macia L, Galvão I, Martins FS, Canesso MC, Amaral FA, Garcia CC, Maslowski KM, De Leon E, Shim D, Nicoli JR, Harper JL, Teixeira MM, Mackay CR (2015) A role for gut microbiota and the metabolite-sensing receptor GPR43 in a murine Model of gout. Arthritis Rheumatol 67(6):1646–1656. doi:10.​1002/​art.​39107 CrossRefPubMed
Metadata
Title
Metabolic characteristics and renal dysfunction in 65 patients with tophi prior to gout
Authors
Chuan-Chin Lu
Shyi-Kuen Wu
Wei-Sheng Chung
Liang-Hung Lin
Ta-Wei Hung
Chih-Jung Yeh
Publication date
01-08-2017
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 8/2017
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3663-0

Other articles of this Issue 8/2017

Clinical Rheumatology 8/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.